JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Karyopharm Therapeutics
KPTI
$14.7M
| $1.26M | ﹤0.01% |
13,684
-218
| -2% | -$17.5K |
2013 Q4
22 quarters
|
|
|
GSKY
3552
PUT
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.25M | ﹤0.01% |
+109,100
| New | +$1.43M |
2019 Q2
0 quarters
|
|
|
COWN
3553
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.25M | ﹤0.01% |
74,655
-51,277
| -41% | -$828K |
2017 Q4
6 quarters
|
|
3554
iShares US Financial Services ETF
IYG
$2.11B
| $1.25M | ﹤0.01% |
28,443
+165
| +0.6% | +$7.23K |
2016 Q1
13 quarters
|
|
|
SUPV
3555
Grupo Supervielle
SUPV
$651M
| $1.25M | ﹤0.01% |
168,731
-632,081
| -79% | -$3.86M |
2017 Q3
7 quarters
|
|
3556
Marten Transport
MRTN
$1.05B
| $1.25M | ﹤0.01% |
105,584
-804
| -0.8% | -$10K |
2015 Q4
14 quarters
|
|
3557
CALL
Equinix
EQIX
$103B
| $1.25M | ﹤0.01% |
+2,500
| New | +$1.2M |
2019 Q2
0 quarters
|
|
|
3558
PUT
Equinix
EQIX
$103B
| $1.25M | ﹤0.01% |
+2,500
| New | +$1.2M |
2019 Q2
0 quarters
|
|
|
AMAG
3559
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.24M | ﹤0.01% |
130,445
-2,466
| -2% | -$26.6K |
2013 Q2
24 quarters
|
|
3560
Valhi
VHI
$428M
| $1.24M | ﹤0.01% |
38,515
+9,593
| +33% | +$268K |
2016 Q4
10 quarters
|
|
|
PLAN
3561
PUT
DELISTED
Anaplan, Inc.
PLAN
| $1.24M | ﹤0.01% |
+25,000
| New | +$1.03M |
2019 Q2
0 quarters
|
|
3562
Inovio Pharmaceuticals
INO
$117M
| $1.24M | ﹤0.01% |
35,368
+32,917
| +1,343% | +$1.31M |
2014 Q3
19 quarters
|
|
3563
CALL
Arista Networks
ANET
$272B
| $1.24M | ﹤0.01% |
+76,800
| New | +$1.33M |
2019 Q2
0 quarters
|
|
3564
Global Indemnity Group
GBLI
$352M
| $1.24M | ﹤0.01% |
42,206
+211
| +0.5% | +$6.38K |
2013 Q2
24 quarters
|
|
|
CNBKA
3565
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.24M | ﹤0.01% |
14,114
+2,032
| +17% | +$178K |
2013 Q2
24 quarters
|
|
3566
Stock Yards Bancorp
SYBT
$2.39B
| $1.23M | ﹤0.01% |
34,172
+1,290
| +4% | +$44.6K |
2013 Q2
24 quarters
|
|
|
XLRN
3567
CALL
DELISTED
Acceleron Pharma
XLRN
| $1.23M | ﹤0.01% |
30,000
-70,100
| -70% | -$2.9M |
2018 Q2
4 quarters
|
|
|
XLRN
3568
PUT
DELISTED
Acceleron Pharma
XLRN
| $1.23M | ﹤0.01% |
30,000
-10,000
| -25% | -$414K |
2018 Q4
2 quarters
|
|
3569
Cannae Holdings
CNNE
$672M
| $1.23M | ﹤0.01% |
42,963
-82,989
| -66% | -$2.19M |
2017 Q4
6 quarters
|
|
3570
Neogen
NEOG
$2.61B
| $1.23M | ﹤0.01% |
40,248
+6,712
| +20% | +$198K |
2015 Q3
15 quarters
|
|
|
PRA
3571
DELISTED
ProAssurance
PRA
| $1.23M | ﹤0.01% |
34,053
-1,034,529
| -97% | -$38.5M |
2013 Q2
24 quarters
|
|
3572
CNA Financial
CNA
$12.5B
| $1.23M | ﹤0.01% |
26,441
+15,899
| +151% | +$724K |
2015 Q2
16 quarters
|
|
|
HUCK
3573
PUT
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$147M
| $1.22M | ﹤0.01% |
+43,800
| New | +$1.52M |
2019 Q2
0 quarters
|
|
|
TYPE
3574
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.22M | ﹤0.01% |
72,780
+2,573
| +4% | +$45.8K |
2013 Q2
24 quarters
|
|
|
ENBL
3575
CALL
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.22M | ﹤0.01% |
+90,600
| New | +$1.23M |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.